| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $24.4M | +0.6% |
| SG&A Expense | $12.5M | -2.6% |
| Pre-tax Income | -$35.2M | +4.4% |
| Income Tax | -$112K | -225.5% |
| Net Income | -$35.1M | +4.6% |
| EPS (Basic) | -$0.80 | +16.7% |
| EPS (Diluted) | -$0.80 | +16.7% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $57.1M | -58.6% |
| Short-term Investments | $110.2M | +92.9% |
| Accounts Receivable | $6K | -98.7% |
| Current Assets | $169.1M | -14.4% |
| Total Assets | $169.5M | -14.5% |
| Current Liabilities | $2.3M | -41.2% |
| Total Liabilities | $2.4M | -42.6% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.7M | -12.9% |
| Investing Cash Flow | -$52.3M | -49.5% |
| Financing Cash Flow | $253K | -99.8% |
| Stockholders' Equity |
| $167.1M |
| -13.9% |